Cardiac gene therapy represents a cutting-edge approach in the realm of cardiovascular medicine, holding immense promise for the treatment of various heart-related conditions. This innovative therapeutic strategy involves the introduction of specific genes into the heart with the aim of correcting or modulating genetic defects, enhancing myocardial function, and mitigating the progression of cardiac diseases. By leveraging the potential of gene delivery systems, researchers are exploring avenues to address conditions such as heart failure, hypertrophic cardiomyopathy, and other genetic cardiovascular disorders. The evolving field of cardiac gene therapy signifies a paradigm shift, offering hope for more targeted and personalized interventions in the quest for improved heart health. As scientists continue to unravel the complexities of cardiac genetics, the potential for groundbreaking advancements in treating cardiovascular diseases through gene-based approaches remains a captivating area of exploration and development.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China